List view / Grid view
19 February 2015 | By Eli Lilly and Company
Eli Lilly and Company has accepted the recommendation of the ACCELERATE study academic executive committee, based on emerging science in the cardiovascular field, to extend the Phase 3 trial of the investigational medicine evacetrapib by approximately six months...
19 February 2015 | By Midatech Pharma
Sustained release OpsiSporin as efficacious as orally administered Cyclosporin A at one thousandth of the dose...
19 February 2015 | By BIOTRONIK
BIOTRONIK announced the completion of enrollment in the BIOSOLVE-II trial - a clinical study investigating the safety and performance of DREAMS (DRug Eluting Absorbable Metal Scaffold)...
19 February 2015 | By Arthur J. Gallagher / J A Kemp
BUSINESSES from across the Life Science community came together in Oxford to learn more about the importance of protecting their companies’ intellectual property assets at a free workshop run by commercial insurance broker Arthur J. Gallagher and patent and trade mark attorney firm, J A Kemp...
19 February 2015 | By Roche
Roche announced the U.S. Food and Drug Administration has accepted and granted priority review for the company’s New Drug Application for cobimetinib in combination with Zelboraf® (vemurafenib) for the treatment of people with BRAF V600 mutation-positive advanced melanoma...
18 February 2015 | By Lund University
A new report from Lund University in Sweden shows how the pharmaceutical industry time and again violates regulations on the marketing of drugs...
18 February 2015 | By Lions Health
Lions Health together with UNICEF and Unilever, launched the Young Lions Health Award, an exciting new competition for young creatives and marketers that aims to improve challenges facing global health systems in developing countries...
18 February 2015 | By GlobalData
The Chinese treatment market for colorectal cancer will expand almost fourfold in value from an estimated $259 million in 2013 to $1.05 billion by 2023, at an impressive Compound Annual Growth Rate of 15.1%, according to research and consulting firm GlobalData...
18 February 2015 | By Moberg Pharma
On February 27, at 08:00 CET, Moberg Pharma AB (OMX: MOB) will publish its report for the fourth quarter and full year 2014...
17 February 2015 | By BIOTRONIK
ProMRI studies published in Heart Rhythm, the official journal of the Heart Rhythm Society, have confirmed the safety of MR imaging with BIOTRONIK devices...
17 February 2015 | By GlobalData
Insomnia drug sales will fall rapidly from $2.1 billion in 2013 to $1.4 billion by 2016, before steadily recovering to $1.8 billion by 2023, driven by the launch of two products, Merck & Co.’s Belsomra and Eisai’s E-2006, and an increase in the prevalent cases of insomnia, says research and…
17 February 2015 | By Frost & Sullivan
New Frost & Sullivan Insights uncover the booming business potential for health services in 16 countries, among which Russia, Turkey, Kazakhstan, Greece, Bulgaria and the CIS...
17 February 2015 | By Public Health England
Public Health England (PHE) can confirm that a UK healthcare worker who had potential contact with the Ebola virus while working in Sierra Leone, is being transported to the UK for assessment and monitoring.
17 February 2015 | By Lucideon
Lucideon has launched iCRT-deter, a new delivery platform technology that provides abuse deterrent controlled release for pharmaceutical applications...
17 February 2015 | By Mundipharma
Mundipharma to provide supplies for at least two million handwashes in Ebola treatment centres...
